Pediatric Cardiac Surgery Overview

Principles

Definition

Pediatric cardiac surgery is a specialized academic and clinical discipline focused on the surgical treatment of congenital and acquired heart diseases in infants, children, and adolescents. As a research field, it investigates the unique anatomical and physiological challenges of the developing cardiovascular system, surgical techniques, outcomes, and long-term impact, aiming to advance therapeutic strategies and improve patient prognosis.

Ontological type

Surgical Techniques

Outcomes and Complications

Perioperative Management

Key developments

Key Figures

Operative Capability Expansion era

Gordon K. Danielson [1] was a leading pediatric cardiac surgeon during this era, with affiliations at the University of Pennsylvania [3] and the University of Washington [4]. His key contributions include the Modified Fontan operation for univentricular heart and complicated congenital lesions [7], and investigations into hypertrophic obstructive cardiomyopathy in children and adults under 40 [8], expanding survivable options and informing pediatric surgical strategy in this era. Dwight C. McGoon [2] is associated with the Albert Einstein College of Medicine [5] and the Icahn School of Medicine at Mount Sinai [6] during this period. McGoon's co-authorship on the Fontan modification [7] helped broaden the therapeutic repertoire and advance staged palliation, features that defined the era's expansion of operative capability for congenital heart disease.

Perioperative Physiology Optimization era

David Wessel [1] emerged as a leading figure at Harvard University [3] and Northwestern University [4] during the Perioperative Physiology Optimization era (1994-2007). His key contributions include the Milrinone study, Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease [7], and Anatomic subtype and survival after reconstructive operation for hypoplastic left heart syndrome [8], which shaped perioperative hemodynamic management and risk stratification in this era. Thomas L. Spray [2] had research ties to Johns Hopkins University [5] and the University of Pennsylvania [6] during this period. His singular contribution in this era centers on the Milrinone study [7], which demonstrated potential benefits in preventing low cardiac output syndrome and informed hemodynamic optimization across centers.

Registry-Driven Quality Improvement era

Josef Stehlik[1] is a leading figure in pediatric cardiac surgery whose work in the Registry-Driven Quality Improvement era spanned institutions such as Stanford University[3] and Baylor College of Medicine[4]. His contributions include using multicenter transplant registries to establish mortality risk models and center-level benchmarking, as reflected in the Thirteenth official pediatric heart transplantation report—2010[7], the Twelfth Official Pediatric Heart Transplantation Report—2009[9], and the Twenty-first pediatric heart transplantation report—2018[8], which collectively advanced data-driven policy and practice in this era. Anna Y. Kucheryavaya[2] is a key contributor whose work in this era connected University of Minnesota[5] and University of Utah[6] with registry-based pediatric transplantation data. Her key contributions include coordinating the reporting and meta-analysis of the registry findings—The Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Heart Transplantation Report—2009[9], The Registry of the International Society for Heart and Lung Transplantation: Thirteenth official pediatric heart transplantation report—2010[7], and The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report—2018[8]—to enable risk-adjusted benchmarking and standardized surveillance during registry-driven quality improvement.